Complementary Treatment of Breast Cancer Cells with Different Metastatic Potential with Iscador Qu in the Presence of Clinically Approved Anticancer Drugs

Complementary Treatment of Breast Cancer Cells with Different Metastatic Potential with Iscador Qu in the Presence of Clinically Approved Anticancer Drugs

European mistletoe extract (Iscador Qu) has been studied for decades, but it has not ceased to arouse scientific interest. The purpose was to investigate the impact of Iscador Qu on the antiproliferative potential of 11 standard chemotherapeutic agents on two breast cancer cell lines: MCF-7 low-meta...

Full description

Saved in:
Bibliographic Details
Main Authors: Ivan Iliev, Iana Tsoneva, Aleksandrina Nesheva, Galya Staneva, Bozhil Robev, Albena Momchilova, Biliana Nikolova
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Current Issues in Molecular Biology
Subjects:
Iscador Qu
antiproliferative activity
cytotoxicity
breast cancer cells
anticancer drugs
complementary treatment
Online Access:https://www.mdpi.com/1467-3045/46/11/740
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1467-3045/46/11/740

Similar Items